Peripheral Artery Stent Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 2.4 Billion by 2030, growing at a CAGR of 6.5% from 2024 to 2030.
The Peripheral Artery Stent Market is an essential sector within the broader cardiovascular device industry, characterized by the use of stents to treat peripheral artery disease (PAD). These stents are employed to maintain the patency of arteries that become narrowed or blocked due to the buildup of plaque or other factors. The market is categorized by application, with notable subsegments such as Lower Limbs, Renal Artery, and Carotid Artery, each serving distinct clinical needs and presenting unique challenges and opportunities. Peripheral artery stents are crucial in improving blood flow to affected regions, thus reducing the risk of complications such as amputation or stroke. The market for these devices is expanding, driven by increasing prevalence of vascular diseases, the aging global population, and advancements in stent technology. As the market grows, it faces evolving regulatory landscapes and the need for more effective, durable, and minimally invasive treatment options.
Download Full PDF Sample Copy of Global Peripheral Artery Stent Report @ https://www.verifiedmarketreports.com/download-sample/?rid=372206&utm_source=Google_site&utm_medium=227
The Peripheral Artery Stent Market by application plays a pivotal role in addressing the growing prevalence of peripheral artery disease (PAD), a condition that occurs when the arteries, particularly in the lower limbs, become narrowed or blocked. This condition affects millions globally, leading to symptoms such as pain, numbness, and in severe cases, gangrene or amputation. Lower limb stents are designed to restore blood flow to the legs and feet, preventing these adverse outcomes and improving the patient's quality of life. These stents are often used in conjunction with other treatments like angioplasty, and technological advancements are continually improving their effectiveness, reducing complications, and increasing patient satisfaction. With the rise in lifestyle diseases such as diabetes and hypertension, which contribute to the increasing incidence of PAD, the lower limb stent segment of the market is expected to maintain a strong growth trajectory over the coming years.The lower limbs are the most common site for peripheral artery interventions, as this region is especially vulnerable to plaque buildup due to its distance from the heart and lower blood pressure. This subsegment is characterized by the use of drug-eluting and balloon-expandable stents, which help to maintain arterial patency after initial dilation. Moreover, the demand for minimally invasive procedures is driving the growth of stent placements over traditional surgeries. Newer innovations, such as bioabsorbable stents and self-expanding stents, are expected to further improve outcomes for patients suffering from PAD in the lower limbs. As healthcare systems globally are under increasing pressure to treat chronic conditions efficiently, the development of more durable, cost-effective stent options will also fuel growth in this application segment.
The renal artery stent segment addresses one of the most critical applications of peripheral artery interventions: the treatment of renal artery stenosis (RAS). This condition involves the narrowing of the arteries that supply blood to the kidneys, which can lead to hypertension, kidney damage, and even renal failure if untreated. Renal artery stents are employed to restore proper blood flow and lower blood pressure in patients with RAS, ultimately improving kidney function and reducing the risk of complications. The market for renal artery stents is growing due to the increasing global prevalence of hypertension and a rising number of elderly patients who are more susceptible to kidney diseases. Moreover, as the aging population grows, so too does the incidence of comorbidities like diabetes and chronic kidney disease (CKD), which further fuels demand for stents in this application.This subsegment is experiencing significant technological advancements, with the introduction of stents specifically designed for the renal arteries, featuring unique designs that minimize vessel trauma and promote optimal blood flow. The development of drug-eluting stents, which release medication to prevent restenosis (the re-narrowing of arteries), has proven beneficial in reducing the need for repeat interventions. However, challenges remain regarding the long-term efficacy and complications related to renal artery stenting, including the potential for renal impairment and stent thrombosis. As medical professionals continue to explore the best treatment options for patients with renal artery disease, the renal artery stent market will likely see continued growth, driven by improvements in stent technology and patient outcomes.
The carotid artery stent market focuses on a specialized segment aimed at treating carotid artery stenosis, a condition where the major arteries in the neck become narrowed, leading to an increased risk of stroke. Carotid artery stenting (CAS) is a less invasive alternative to carotid endarterectomy (CEA), which is a surgical procedure to remove plaque from the carotid arteries. Stents are used to open up blocked or narrowed arteries, restoring blood flow to the brain and significantly reducing stroke risk. This subsegment is gaining traction due to the growing number of patients diagnosed with carotid artery disease, particularly among older adults and those with risk factors like high cholesterol and smoking. Carotid artery stents have proven to be effective in preventing strokes in patients who are not suitable candidates for surgery or in cases where surgery has failed.The development of stents for carotid artery disease is a rapidly evolving area, with ongoing advancements aimed at reducing complications and improving patient outcomes. Drug-eluting stents, which help prevent restenosis, and covered stents, which provide extra protection against embolic events, are expected to drive growth in this segment. The preference for minimally invasive procedures over traditional surgeries, as well as improvements in stent technology to reduce complications such as thrombosis and restenosis, will continue to propel the carotid artery stent market. As the prevalence of stroke continues to rise globally, driven by lifestyle factors and an aging population, the demand for carotid artery stents is expected to grow, offering substantial opportunities for innovation in the treatment of carotid artery stenosis.
One of the key trends driving the Peripheral Artery Stent Market is the increasing preference for minimally invasive procedures. As healthcare providers and patients alike seek alternatives to traditional surgical methods, the demand for peripheral artery stenting has surged. The evolution of stent designs, such as drug-eluting stents, bioabsorbable stents, and self-expanding stents, has led to improvements in both the efficacy and safety of these devices. These innovations reduce the risk of complications such as restenosis and stent thrombosis, allowing for better patient outcomes and shorter recovery times. Moreover, the ongoing trend toward minimally invasive treatments is encouraging the development of stents that are easier to deploy and that reduce the need for follow-up procedures.Another prominent trend is the increasing adoption of advanced imaging and navigation technologies, which play a critical role in the accurate placement of peripheral artery stents. Technologies such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT) have revolutionized the way doctors visualize and navigate within blood vessels during stent placement. This trend is enabling more precise interventions, reducing complications, and improving long-term patient outcomes. Additionally, these technologies are contributing to the expansion of the market by offering a less invasive approach to stent insertion, which is becoming increasingly popular among patients seeking faster recovery times.
The Peripheral Artery Stent Market presents significant opportunities for growth, particularly in emerging economies where the prevalence of peripheral artery disease is rising due to lifestyle changes and an aging population. In these regions, increasing access to healthcare and improving medical infrastructure create favorable conditions for the adoption of stents. Additionally, there is a growing focus on chronic disease management, with peripheral artery disease being one of the most common vascular diseases in these regions. As healthcare systems improve, there will be an increasing demand for stents as part of broader cardiovascular disease management strategies.Furthermore, technological advancements represent a substantial opportunity for companies operating in the Peripheral Artery Stent Market. The development of stents that offer improved durability, reduced complication rates, and enhanced patient comfort is opening new doors for innovation. Research and development in areas such as bioabsorbable stents, drug-eluting stents, and next-generation imaging technologies are poised to create high-growth avenues. Collaborations between medical device companies, healthcare providers, and academic institutions will foster the development of new, more effective products, driving the future of the market and enabling better management of peripheral artery disease.
1. What is a peripheral artery stent used for?
A peripheral artery stent is used to treat narrowing or blockage of arteries in the legs, kidneys, or carotid arteries by restoring blood flow and preventing complications.
2. How does a stent work in the body?
A stent works by being placed in a narrowed artery to help keep it open, ensuring continuous blood flow to vital organs and tissues.
3. Are peripheral artery stents safe?
Yes, peripheral artery stents are generally safe, though there are risks of complications such as infection or restenosis, which are minimized through advancements in stent technology.
4. What are the types of peripheral artery stents?
Common types include balloon-expandable, self-expanding, and drug-eluting stents, each designed for specific applications and patient needs.
5. How long do peripheral artery stents last?
Peripheral artery stents are typically designed to be permanent, although the lifespan can depend on the type of stent and the patient’s health conditions.
6. Can peripheral artery stents be removed?
In most cases, peripheral artery stents are not removed as they are designed to remain in place to maintain the artery's openness.
7. What are the risks associated with peripheral artery stenting?
Risks include bleeding, infection, clot formation, or restenosis,
Download Full PDF Sample Copy of Global Peripheral Artery Stent Report @ https://www.verifiedmarketreports.com/download-sample/?rid=372206&utm_source=Google_site&utm_medium=227
Medtronic
Inc.
BD
Boston Scientific Corporation
Abbott Laboratories
Cordis
Biotronik
Terumo Corporation
Shanghai MicroPort Endovascular MedTech（Group）Co.
Ltd.
Cook Medical
Zylox-Tonbridge Medical Technology Co.
Ltd.
LifeTech Scientific Corporation
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase Of This Report @ https://www.verifiedmarketreports.com/ask-for-discount/?rid=372206&utm_source=Google_site&utm_medium=227
Growing demand for below applications around the world has had a direct impact on the growth of the Global Peripheral Artery Stent Market
Lower Limbs
Renal Artery
Carotid Artery
Based on Types the Market is categorized into Below types that held the largest Peripheral Artery Stent market share In 2023.
Balloon Expandable Stent
Self Expandable Stent
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
1. Introduction of the Global Peripheral Artery Stent Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Peripheral Artery Stent Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Peripheral Artery Stent Market, By Type
6. Global Peripheral Artery Stent Market, By Application
7. Global Peripheral Artery Stent Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Peripheral Artery Stent Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/